These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Icariside II, a Prenyl-Flavonol, Alleviates Inflammatory and Neuropathic Pain by Inhibiting T-Type Calcium Channels and USP5-Cav3.2 Interactions. Ali MY; Gadotti VM; Huang S; Garcia-Caballero A; Antunes FTT; Jung HA; Choi JS; Zamponi GW ACS Chem Neurosci; 2023 May; 14(10):1859-1869. PubMed ID: 37116219 [TBL] [Abstract][Full Text] [Related]
8. A Synthetically Accessible Small-Molecule Inhibitor of USP5-Cav3.2 Calcium Channel Interactions with Analgesic Properties. Garcia-Caballero A; Gadotti VM; Ali MY; Bladen C; Gambeta E; Van Humbeck JF; MacCallum JL; Zamponi GW ACS Chem Neurosci; 2022 Feb; 13(4):524-536. PubMed ID: 35113527 [TBL] [Abstract][Full Text] [Related]
9. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia. Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553 [TBL] [Abstract][Full Text] [Related]
10. NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors. Berger ND; Gadotti VM; Petrov RR; Chapman K; Diaz P; Zamponi GW Mol Pain; 2014 Dec; 10():77. PubMed ID: 25481027 [TBL] [Abstract][Full Text] [Related]
11. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels. Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819 [TBL] [Abstract][Full Text] [Related]
12. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats. Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441 [TBL] [Abstract][Full Text] [Related]
13. Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells. Sekiguchi F; Miyamoto Y; Kanaoka D; Ide H; Yoshida S; Ohkubo T; Kawabata A Biochem Biophys Res Commun; 2014 Feb; 445(1):225-9. PubMed ID: 24508802 [TBL] [Abstract][Full Text] [Related]
15. Colocalization of insulin-like growth factor-1 receptor and T type Cav3.2 channel in dorsal root ganglia in chronic inflammatory pain mouse model. Lin SF; Yu XL; Wang B; Zhang YJ; Sun YG; Liu XJ Neuroreport; 2016 Jul; 27(10):737-43. PubMed ID: 27213932 [TBL] [Abstract][Full Text] [Related]
16. Neuromedin B receptor stimulation of Cav3.2 T-type Ca Zhang Y; Qian Z; Jiang D; Sun Y; Gao S; Jiang X; Wang H; Tao J Theranostics; 2021; 11(19):9342-9357. PubMed ID: 34646374 [No Abstract] [Full Text] [Related]
17. Melatonin-mediated inhibition of Cav3.2 T-type Ca Zhang Y; Ji H; Wang J; Sun Y; Qian Z; Jiang X; Snutch TP; Sun Y; Tao J J Pineal Res; 2018 May; 64(4):e12476. PubMed ID: 29437250 [TBL] [Abstract][Full Text] [Related]
18. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. Barbara G; Alloui A; Nargeot J; Lory P; Eschalier A; Bourinet E; Chemin J J Neurosci; 2009 Oct; 29(42):13106-14. PubMed ID: 19846698 [TBL] [Abstract][Full Text] [Related]
19. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons. Watanabe M; Ueda T; Shibata Y; Kumamoto N; Shimada S; Ugawa S PLoS One; 2015; 10(5):e0127572. PubMed ID: 25974104 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury. Yue J; Liu L; Liu Z; Shu B; Zhang Y Spine (Phila Pa 1976); 2013 Mar; 38(6):463-70. PubMed ID: 22972512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]